Lucas Hill

502 total citations
35 papers, 374 citations indexed

About

Lucas Hill is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Lucas Hill has authored 35 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 18 papers in Hepatology and 17 papers in Epidemiology. Recurrent topics in Lucas Hill's work include HIV/AIDS drug development and treatment (21 papers), Hepatitis C virus research (18 papers) and HIV/AIDS Research and Interventions (13 papers). Lucas Hill is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), Hepatitis C virus research (18 papers) and HIV/AIDS Research and Interventions (13 papers). Lucas Hill collaborates with scholars based in United States, Australia and United Kingdom. Lucas Hill's co-authors include Edward R. Cachay, Craig Ballard, Francesca J. Torriani, William C. Mathews, David Wyles, Laura Bamford, Jeffrey Yin, Maile Karris, Darcy Wooten and Alexander Kuo and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Lucas Hill

34 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucas Hill United States 13 229 215 202 65 33 35 374
Laura Benítez‐Gutiérrez Spain 13 310 1.4× 278 1.3× 148 0.7× 49 0.8× 19 0.6× 20 414
Deborah D. Brown United States 4 376 1.6× 334 1.6× 177 0.9× 34 0.5× 11 0.3× 5 450
Andrea Bregenzer Switzerland 8 289 1.3× 305 1.4× 166 0.8× 43 0.7× 42 1.3× 16 384
Ana Arizcorreta Spain 7 382 1.7× 316 1.5× 108 0.5× 44 0.7× 49 1.5× 12 428
Juan González Spain 7 285 1.2× 355 1.7× 223 1.1× 63 1.0× 61 1.8× 14 467
D. Nolan Australia 6 129 0.6× 172 0.8× 236 1.2× 90 1.4× 171 5.2× 11 370
Ana Arias Spain 7 192 0.8× 175 0.8× 105 0.5× 44 0.7× 15 0.5× 12 279
Monica Schiavini Italy 9 214 0.9× 223 1.0× 91 0.5× 31 0.5× 65 2.0× 23 315
Paula G. Smith United States 10 336 1.5× 366 1.7× 48 0.2× 19 0.3× 54 1.6× 11 428
José del Valle Spain 9 308 1.3× 284 1.3× 92 0.5× 27 0.4× 43 1.3× 12 379

Countries citing papers authored by Lucas Hill

Since Specialization
Citations

This map shows the geographic impact of Lucas Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Hill more than expected).

Fields of papers citing papers by Lucas Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Hill. The network helps show where Lucas Hill may publish in the future.

Co-authorship network of co-authors of Lucas Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Hill. A scholar is included among the top collaborators of Lucas Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Hill. Lucas Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hill, Lucas, et al.. (2025). Long-Acting Injectable HIV Therapy Outcomes Among Persons With HIV Who Have Adherence Challenges to Oral Antiretroviral Therapy. Clinical Infectious Diseases. 81(3). 543–546. 3 indexed citations
2.
Wooten, Darcy, Daniel Lee, Manuel Moreno, et al.. (2024). Glucagon-like Peptide 1 Receptor Agonists Promote Weight Loss Among People With HIV. Clinical Infectious Diseases. 79(4). 978–982. 10 indexed citations
3.
Gandhi, Monica, Lucas Hill, Janet Grochowski, et al.. (2024). Case Series of People With HIV on the Long-Acting Combination of Lenacapavir and Cabotegravir: Call for a Trial. Open Forum Infectious Diseases. 11(4). ofae125–ofae125. 22 indexed citations
4.
Mathews, William C., Adriane Wynn, Francesca J. Torriani, et al.. (2023). Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track?. Open Forum Infectious Diseases. 10(4). ofad153–ofad153. 1 indexed citations
5.
6.
7.
Nguyen, Quynh, Darcy Wooten, Manuel Moreno, et al.. (2023). 1982. GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV. Open Forum Infectious Diseases. 10(Supplement_2). 3 indexed citations
8.
Yin, Jeffrey, et al.. (2023). Successful treatment of hepatitis C virus infection in patients on anti‐epileptics or mood stabilizers using pharmacokinetic enhancers. British Journal of Clinical Pharmacology. 89(6). 1891–1895. 1 indexed citations
9.
Hill, Lucas, et al.. (2022). Single-center experience evaluating and initiating people with HIV on long-acting cabotegravir/rilpivirine. AIDS. 37(4). 605–609. 17 indexed citations
10.
11.
Cachay, Edward R., Álvaro Mena, Luís Morano, et al.. (2021). Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach. Journal of the International Association of Providers of AIDS Care (JIAPAC). 20. 2135943043–2135943043. 2 indexed citations
12.
Martin, Thomas, et al.. (2020). Tenofovir alafenamide and rifabutin co-administration does not lead to loss of HIV-1 suppression: A retrospective observational study. International Journal of Infectious Diseases. 100. 470–472. 4 indexed citations
13.
Cachay, Edward R., Francesca J. Torriani, Lucas Hill, et al.. (2020). The role of barriers to care on the propensity for hepatitis C virus nonreferral among people living with HIV. AIDS. 34(11). 1681–1683. 3 indexed citations
14.
Ballard, Craig, Edward R. Cachay, & Lucas Hill. (2019). The Role of the Clinical Pharmacist in the Management of People Living with HIV in the Modern Antiretroviral Era. PubMed. 21(4). 195–210. 8 indexed citations
15.
Hill, Lucas, et al.. (2018). Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date. HIV/AIDS - Research and Palliative Care. Volume 10. 203–213. 13 indexed citations
16.
Hill, Lucas & David Wyles. (2017). Future Paradigms of HCV Management with Resistance Testing. Current Hepatology Reports. 16(1). 1–11. 1 indexed citations
17.
Cachay, Edward R., Lucas Hill, David Wyles, et al.. (2014). The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care. PLoS ONE. 9(7). e102883–e102883. 58 indexed citations
18.
Cachay, Edward R., David Wyles, Francesca J. Torriani, et al.. (2013). High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen. AIDS. 27(18). 2893–2897. 12 indexed citations
19.
Cachay, Edward R., Lucas Hill, Craig Ballard, et al.. (2013). Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model. AIDS Research and Therapy. 10(1). 9–9. 18 indexed citations
20.
Hirschberg, David L., George J. Schreiber, K Thor, et al.. (1991). Monoclonal antibody L6-daunomycin conjugates constructed to release free drug at the lower pH of tumor tissue. Cancer Immunology Immunotherapy. 33(4). 223–230. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Benítez‐Gutiérrez Breakdown of academic impact, for papers by Deborah D. Brown Breakdown of academic impact, for papers by Andrea Bregenzer Breakdown of academic impact, for papers by Ana Arizcorreta Breakdown of academic impact, for papers by Juan González Breakdown of academic impact, for papers by D. Nolan Breakdown of academic impact, for papers by Ana Arias Breakdown of academic impact, for papers by Monica Schiavini Breakdown of academic impact, for papers by Paula G. Smith Breakdown of academic impact, for papers by José del Valle
Rankless by CCL
2026